💊 ยา A-Z 🧬 เป้าหมาย 🛠 เครื่องมือ 📚 คู่มือ
ยาทั้งหมด หมวดหมู่ยา ด้านการรักษา ผลข้างเคียง
คู่มือ อภิธานศัพท์ ไทม์ไลน์
การเปรียบเทียบ เส้นทางของยา กลุ่มยา
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Technetium Tc 99M Bicisate

CHEMBL1237111 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
434.3 g/mol
LogP
—
Phase
4

Technetium Tc 99m bicisate (99mTc-ECD) is a lipophilic ester that diffuses freely across the blood-brain barrier and is subsequently hydrolyzed intracellularly to a charged form that is retained in brain tissue, enabling SPECT cerebral perfusion imaging. It is used in the evaluation of stroke, epilepsy, dementia, and other cerebrovascular conditions. See technetium-bicisate for additional pharmacological details.

น้ำหนักโมเลกุล

434.3000 g/mol

TPSA

68.60 Ų

ด้านการรักษา

Epilepsy

Pharmacokinetics (PK)

Pharmacodynamics (PD)

SMILES

CCOC(=O)[C@H](C[S-])NCC[N-][C@@H](C[S-])C(=O)OCC.[O-2].[Tc]

InChI

InChI=1S/C12H23N2O4S2.O.Tc/c1-3-17-11(15)9(7-19)13-5-6-14-10(8-20)12(16)18-4-2;;/h9-10,13,19-20H,3-8H2,1-2H3;;/q-1;-2;/p-2/t9-,10-;;/m0../s1

Molecular Formula

C12H21N2O5S2Tc-5

HBD / HBA

1 / 9

พันธะที่หมุนได้

13

อะตอมหนัก

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Technetium Tc 99m bicisate (99mTc-ECD) is a lipophilic ester that diffuses freely across the blood-brain barrier and is subsequently hydrolyzed intracellularly to a charged form that is retained in brain tissue, enabling SPECT cerebral perfusion imaging. It is used in the evaluation of stroke, epilepsy, dementia, and other cerebrovascular conditions. See technetium-bicisate for additional pharmacological details.

Yes, Technetium Tc 99M Bicisate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1237111. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 155491161. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.